Estrogen Receptor Negative Recruiting Phase 1 Trials for Gemcitabine (DB00441)

IndicationStatusPhase
DBCOND0036417 (Estrogen Receptor Negative)Recruiting1
clinicaltrials.gov IdentifierTitlePurposeDrugs